Ocular surface toxicity of depatuxizumab mafoditin (ABT-414): case reports.
Sign Up to like & getrecommendations! Published in 2021 at "Arquivos brasileiros de oftalmologia"
DOI: 10.5935/0004-2749.20220039
Abstract: The purpose of this study is to report the clinical features and outcomes of ocular surface toxicity following depatuxizumab mafoditin (ABT-414) therapy for unresectable glioblastoma. Ocular signs and symptoms of three patients treated with ABT-414… read more here.
Keywords: depatuxizumab mafoditin; abt 414; ocular surface; surface toxicity ... See more keywords